Charles Schwab’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,508,377
Closed -$3.11M 3626
2022
Q4
$3.11M Buy
3,508,377
+674,716
+24% +$598K ﹤0.01% 2421
2022
Q3
$4.45M Buy
2,833,661
+66,757
+2% +$105K ﹤0.01% 2268
2022
Q2
$5.56M Buy
2,766,904
+565,217
+26% +$1.14M ﹤0.01% 2141
2022
Q1
$5.13M Buy
2,201,687
+58,593
+3% +$137K ﹤0.01% 2266
2021
Q4
$9.97M Buy
2,143,094
+110,344
+5% +$513K ﹤0.01% 2007
2021
Q3
$15.5M Buy
2,032,750
+302,190
+17% +$2.31M 0.01% 1764
2021
Q2
$16.8M Buy
1,730,560
+91,306
+6% +$885K 0.01% 1708
2021
Q1
$13.6M Buy
1,639,254
+116,705
+8% +$965K 0.01% 1781
2020
Q4
$10.4M Buy
1,522,549
+152,480
+11% +$1.04M ﹤0.01% 1850
2020
Q3
$15.3M Buy
1,370,069
+927,446
+210% +$10.3M 0.01% 1394
2020
Q2
$2.78M Buy
442,623
+117,131
+36% +$736K ﹤0.01% 2298
2020
Q1
$599K Buy
325,492
+8,463
+3% +$15.6K ﹤0.01% 2652
2019
Q4
$1.07M Buy
317,029
+23,894
+8% +$80.8K ﹤0.01% 2574
2019
Q3
$628K Buy
293,135
+18,689
+7% +$40K ﹤0.01% 2714
2019
Q2
$733K Buy
274,446
+40,192
+17% +$107K ﹤0.01% 2678
2019
Q1
$1.11M Sell
234,254
-38,411
-14% -$183K ﹤0.01% 2520
2018
Q4
$655K Buy
272,665
+35,590
+15% +$85.5K ﹤0.01% 2668
2018
Q3
$1.04M Buy
237,075
+57,136
+32% +$252K ﹤0.01% 2611
2018
Q2
$1.3M Buy
179,939
+162,000
+903% +$1.17M ﹤0.01% 2505
2018
Q1
$93K Buy
+17,939
New +$93K ﹤0.01% 3045
2017
Q2
Sell
-39,855
Closed -$158K 3156
2017
Q1
$158K Hold
39,855
﹤0.01% 2963
2016
Q4
$196K Hold
39,855
﹤0.01% 2966
2016
Q3
$309K Hold
39,855
﹤0.01% 2784
2016
Q2
$224K Hold
39,855
﹤0.01% 2894
2016
Q1
$215K Hold
39,855
﹤0.01% 2879
2015
Q4
$348K Hold
39,855
﹤0.01% 2803
2015
Q3
$335K Sell
39,855
-1,100
-3% -$9.25K ﹤0.01% 2780
2015
Q2
$722K Buy
+40,955
New +$722K ﹤0.01% 2547